Tokyo Tape
Sign in
← AFC-HD AMS Life Science

Quarterly report · Q2

2927.TEDINET S100QLNK
Period2022-09-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥12.4bn2022-09-01 → 2023-02-28Cons.Net sales
Revenue¥23.0bn2021-09-01 → 2022-08-31Cons.Net sales (5-year summary)
Revenue¥11.2bn2021-09-01 → 2022-02-28Cons.Net sales
Operating income¥678m2022-09-01 → 2023-02-28Cons.Operating income
Operating income¥453m2021-09-01 → 2022-02-28Cons.Operating income
Ordinary income¥708m2022-09-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.3bn2021-09-01 → 2022-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥643m2021-09-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥616m2022-09-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥560m2021-09-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥414m2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥735m2021-09-01 → 2022-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥307m2021-09-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥417m2022-09-01 → 2023-02-28Cons.Profit loss
Net income¥307m2021-09-01 → 2022-02-28Cons.Profit loss
Total assets¥39.0bnat 2023-02-28Cons.Assets
Total assets¥37.3bnat 2022-08-31Cons.Assets
Total assets¥35.9bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥26.3bnat 2023-02-28Cons.Liabilities
Total liabilities¥24.9bnat 2022-08-31Cons.Liabilities
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥12.4bnat 2022-08-31Cons.Net assets
Net assets / equity¥12.7bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥10.9bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥10.4bnat 2022-08-31Cons.Cash and deposits
Cash & equivalents¥10.8bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥8.6bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.7bnat 2021-08-31dCons.Cash and cash equivalents
Operating cash flow¥397m2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.5bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥314m2021-09-01 → 2022-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥791m2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.1bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2021-09-01 → 2022-02-28Cons.Net cash provided by used in investment activities
Financing cash flow¥924m2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥1.2bn2021-09-01 → 2022-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥774m2021-09-01 → 2022-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥29.462022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.012022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.332021-09-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.842021-09-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.82021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.452022-09-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥52.082021-09-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.712021-09-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio32.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio33.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Otherother segmentsrevenue2022-09-01 → 2023-02-28¥540m
Otherother segmentsrevenue external2022-09-01 → 2023-02-28¥540m
Otherother segmentssegment profit2022-09-01 → 2023-02-28−¥2m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2023-02-28¥13m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2023-02-28−¥121m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2023-02-28¥940m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2023-02-28¥103m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥933m
Otherother segmentsrevenue2021-09-01 → 2022-02-28¥23m
Otherother segmentsrevenue external2021-09-01 → 2022-02-28¥23m
Otherother segmentssegment profit2021-09-01 → 2022-02-28−¥10m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2021-09-01 → 2022-02-28¥2.3bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2021-09-01 → 2022-02-28¥2.3bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2021-09-01 → 2022-02-28−¥122m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2021-09-01 → 2022-02-28¥441m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2021-09-01 → 2022-02-28¥441m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2021-09-01 → 2022-02-28−¥190m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2021-09-01 → 2022-02-28¥7.6bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2021-09-01 → 2022-02-28¥7.6bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2021-09-01 → 2022-02-28¥992m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2021-09-01 → 2022-02-28¥871m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2021-09-01 → 2022-02-28¥871m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2021-09-01 → 2022-02-28¥85m
Total Of Reportable Segments And Otherssegment totalrevenue2021-09-01 → 2022-02-28¥11.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-09-01 → 2022-02-28¥11.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-09-01 → 2022-02-28¥755m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 536
ItemContextValueUnit
Net cash provided by used in financing activitiesPrior1YTDDuration773742000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration923657000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration6653000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-1883000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-107759000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration527999000JPY
Cash and cash equivalentsPrior2YearInstant8667136000JPY
Cash and cash equivalentsPrior1YearInstant10257778000JPY
Cash and cash equivalentsPrior1QuarterInstant8559377000JPY
Cash and cash equivalentsCurrentQuarterInstant10785778000JPY
Discounted trade notes receivablePrior1YearInstant17408000JPY
Discounted trade notes receivableCurrentQuarterInstant29480000JPY
Advertising expenses sgaPrior1YTDDuration367516000JPY
Advertising expenses sgaCurrentYTDDuration418824000JPY
Salaries and allowances sgaPrior1YTDDuration1145003000JPY
Salaries and allowances sgaCurrentYTDDuration1188103000JPY
Provision for bonuses sgaPrior1YTDDuration77957000JPY
Provision for bonuses sgaCurrentYTDDuration62219000JPY
Retirement benefit expenses sgaPrior1YTDDuration26854000JPY
Retirement benefit expenses sgaCurrentYTDDuration29224000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration14670000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration16445000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration2083000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration1447000JPY
Amortization of goodwill sgaPrior1YTDDuration76495000JPY
Amortization of goodwill sgaCurrentYTDDuration78323000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember7593503000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember871223000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2274093000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember441150000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember22945000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11202916000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember7593503000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember871223000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2274093000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember441150000JPY
Net salesPrior1YTDDuration_OtherReportableSegmentsMember22945000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11202916000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember992441000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember84677000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember-121536000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember-190407000JPY
Operating incomePrior1YTDDuration_OtherReportableSegmentsMember-9935000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember755239000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-08-31pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-09-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2021-09-01/2022-02-28pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-09-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass